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Abstract
Background: Genome annotation plays an essential role in the interpretation and use of genome sequence
information. While great strides have been made in the annotation of coding regions of genes, less success has
been achieved in the annotation of the regulatory regions of genes, including promoters, enhancers/silencers, and
other regulatory elements. One reason for this disparity in annotated information is that coding regions can be
assessed using high-throughput techniques such as EST sequencing, while annotation of regulatory regions often
requires a gene-by-gene approach.
Results: The NFI-Regulome database http://nfiregulome.ccr.buffalo.edu was designed to promote easy annotation
of the regulatory regions of genes that contain binding sites for the NFI (Nuclear Factor I) family of transcription
factors, using data from the published literature. Binding sites are annotated together with the sequence of the
gene, obtained from the UCSC Genome site, and the locations of all binding sites for multiple genes can be
displayed in a number of formats designed to facilitate inter-gene comparisons. Classes of genes based on
expression pattern, disease involvement, or types of binding sites present can be readily compared in order to
assess common “architectural” structures in the regulatory regions.
Conclusions: The NFI-Regulome database allows rapid display of the relative locations and number of transcription
factor binding sites of individual or defined sets of genes that contain binding sites for NFI transcription factors.
This database may in the future be expanded into a distributed database structure including other families of
transcription factors. Such databases may be useful for identifying common regulatory structures in genes essential
for organ development, tissue-specific gene expression or those genes related to specific diseases.
Background
Genome annotation, and the ability to extract and use
information stored in genome databases, is an essential
part of genomic and bioinformatic analysis [1-4]. While
now primarily a basic research tool, analysis of genome
annotation information is rapidly becoming an impor-
tant part of Medical and Health Care informatics.
As more patient genomes are determined, the ability to
correlate changes in the regulatory regions of genes with
specific disease states will become increasingly impor-
tant for Personalized Medicine [5-7].
High-throughput sequencing techniques now allow
human and other complex genomes to be sequenced
relatively easily [8,9]. However determining the func-
tional significance of sequence changes, particularly
changes that affect regulatory elements in the genome, is
still in its infancy. The annotation of regulatory elements
in genomes has lagged behind the analysis of coding
regions [1,2]. While coding regions can be readily
assessed by comparing genome sequence with cDNA
sequences, regulatory regions are still identified primarily
on a gene-by-gene basis. Even with the use of such
powerful tools as whole genome ChIP-seq and the
Encode project [4,10,11], the functional significance of
binding sites found by large scale screening can only be
definitively tested by mutational analysis of binding sites
within genes and determining the effect of loss of binding
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on gene expression. Thus, the wealth of published data
on the analysis of regulatory elements in genes remains
an important asset to be mined by bioinformatic
approaches.
Gene expression can be regulated at many levels
including control of transcription rate, transcript trans-
port and degradation, translation rate, protein folding
and assembly into multi-subunit structures, and protein
stability [12]. We have focused on the analysis of cis-
regulatory elements as mediators of gene expression
[13-17]. In particular, we have created a database for the
annotation and analysis of binding sites for site-specific
transcription factors in the promoter and enhancer
regions of genes. To provide a focus for such a broad
topic, we’ve considered only genes that contain binding
sites for the Nuclear Factor I (NFI) family of transcrip-
tion factors.
The NFI family of transcription factors is essential for
the development of multiple organ systems including
brain, lung, muscle, hematopoietic cells, and teeth [18-21].
The NFI-Regulome database contains the control regions
of genes that have been shown to be regulated by NFI
transcription factors in the primary literature. These con-
trol regions are annotated with transcription start sites,
translation start sites, NFI binding sites, and the location
and identity of other known or unknown site-specific tran-
scription factors. Since there are hundreds of known site-
specific transcription factors [13,16,17], a comprehensive
coverage of all known cis-regulatory sites within a single
database is daunting, therefore restricting our analysis to
NFI-site containing regulatory regions provides us with a
defined starting point for our analysis. Since this gene
family has been shown to be essential for a number of
developmental processes, the database should also provide
useful information on the structures of regulatory regions
of genes involved in development and disease.
Construction and content
Structure
The database is built using MySQL with the MyISAM
engine. This provides the full text support needed for
searches. The table structure is designed to be in first
normal form, which states that the attributes of the rela-
tion contain only atomic values [22]. While third normal
form (3NF) can be achieved easily through the use of an
algorithm [22], the decomposed tables are not practical
for the queries utilized by the website pages. The tables
are separated by major characteristics and generally all
fields of a given table are utilized by a given query. This
enables a single query to retrieve all the information
needed for a particular object such as a binding site or a
gene. In this case performance concerns outweigh the
concerns of anomalies [22] appearing in the relation
scheme. Most situations where anomalies can possibly
occur are handled through the software due to the lim-
itation of MyISAM not having transaction management
or foreign key management.
The overall structure of the tables (Figure 1) was devel-
oped specifically for this database. The tables can be sepa-
rated into smaller groups which have a complete
dependency on each other (Figure 2), two additional tables
provide static information, and one table is used for hold-
ing user information. Each group is responsible for acting
as the data warehouse for a specific set of information.
The AuthorDB and ArticleDB grouping is used for
holding information related to PubMed articles. As the
PubMed ID is a unique feature, it is used in this group-
ing as the primary key. The Author field is set currently
to only 64 characters maximum as no current value
even approaches that maximum. This field maximum
can be adjusted if a value were to supersede this arbi-
trary default. The Abstract field is set to longtext due to
the varying length of article abstracts. Utilizing the MyI-
SAM engine allows for searching of this field for key-
words at the lowest level which is preferable to creating
a piece of software to accomplish the same task.
GeneDB, GeneSynonymDB, SpeciesDB, BindingSiteDB,
and TF_connect_TFBS_DB form the main grouping of
tables used for holding gene and binding site informa-
tion. The TF_connect_TFBS_DB acts as a directory to
allow a gene to know what binding sites it has and for a
binding site to know what gene it belongs to. The Gen-
eDB table includes a Cell_memo field that is used to hold
important keywords. The keywords are generally sepa-
rated by a comma but this is an in-house practice. The
use of MyISAM here allows for this field to be searched
for string values and can be changed to a text type if the
varchar length, currently set to the max of 254, gets
exceeded. GeneSynonymDB provides a table that lists the
alternative names for a particular gene. While this infor-
mation could have been listed underneath the Cell_-
memo field by providing a separate table for this
information, fast indexing and access can be provided.
This feature can be expanded to other attributes located
in the Cell_memo field. The BindingSiteDB table houses
all of the binding site information. This table also
includes a TFBS_memo field which allows an annotator
to list important keywords. In NFI-Regulome these are
separated by commas also. Due to the short length of
binding site sequences, the binding site sequence field
uses a variable type of varchar instead of the longtext
used by GeneDB. The BindingSiteDB table also provides
the link to the previous group by the inclusion of the
Pubmed_id field. The TF_connect_TFBS_DB is the
central table of the entire database. The TF_-
connect_TFBS_DB table connects a particular gene for a
particular species to a particular binding site and gives it
transcription factor information. Most queries utilized by
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the NFI-Regulome website reference the information
provided in this table as the tables are unaware of how
they are related otherwise.
The TFDB, TFSynonymDB and TFFamily tables provide
the last major grouping in the NFI-Regulome database.
Similarly to GeneDB and GeneSynonymDB, TFDB utilizes
TFSynonymDB to house alternative names. TFDB does
include a TF_memo name for keywords that provides the
same role as Cell_memo and TFBS_memo. TFDB has a
TF_family_id field that links TFDB to TFFamily. This rela-
tion is also declared by TF_connect_TFBS_DB.
EvidenceDB and Expression contain static information
and cannot be changed in software at this time. Values
used in these tables have been set and are not expected
to change until the next version of the database. Tables
were used instead of providing enumerated fields for
this information as changes can be made more easily if
they need to be changed in the future.
Figure 1 Table structure of NFI-Regulome Database. Each table is listed along with the fields and their structures.
Figure 2 Structure of NFI-Regulome database grouped by relationships created by the data. Currently these relationships are controlled
by the application layer but in the future will be defined in the underlying database.
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Functions of the Database
The NFI-Regulome database was designed to fulfill mul-
tiple functions: 1) to act as a clearing house and storage
database for all genes known from the primary literature
to be regulated by NFI transcription factors, 2) to allow
rapid analysis and display of defined groups or sets of
NFI-regulated genes, 3) to enable rapid comparisons of
the size, composition, and organizational structure of the
cis-regulatory regions of NFI-regulated genes, selected
either by disease-relevance, cell, tissue or developmental
stage where the gene is expressed, or on the presence of
other transcription factor binding sites, 4) to provide out-
put to other TF binding site annotation databases such as
OregAnno, and 5) to be a prototype database for a com-
prehensive all-transcription factor Regulome database
(see discussion). Each of these functions, along with how
they are performed, is discussed below.
Populating the NFI-Regulome database
Literature references on NFI-regulated genes can be
input automatically from Pubmed with a Perl script, or
can be added individually. Information on the cis-
regulatory regions of genes of NFI-regulated genes is
input by trained Gene Annotators. The papers are read
and a listing of all TF binding sites, transcription start
sites and other relevant information including the bind-
ing site locations and sequence, tissue or cell-type where
the gene is expressed and disease relevance is recorded.
The gene sequence is obtained using the UCSC Genome
Browser and is input into the database. Due to ambigu-
ous or multiple transcript start sites, the translation
start site is used as a defined anchor. A semi-automated
sequence editor and search function is provided to
locate the specific binding sites for each TF in the regu-
latory region of each gene. As of 5/20/2010 there are 70
partially or fully annotated genes with 390 annotated
sites and 574 NFI-related references in the database.
Sites are identified as either experimentally confirmed,
or predicted. The vast majority of sites in the database
are experimentally confirmed. The sizes and locations of
annotated regions correspond to those identified in the
specific literature references and include both promo-
ters, enhancers, and silencer regions. All sites are cur-
rently from individual research papers and no data from
large-scale ChIP have been used. No such large scale
studies have been performed to date for NFI transcrip-
tion factors. Such data will be used when available.
Utility and Discussion
Searching the database and displaying information: Basic
Search Page
The home page of the database is also the Basic Search
page (Figure 3A). It is anticipated that two major search
types will be performed: 1) searching for specific TF
binding sites and outputting all genes containing these
sites and 2) searching for genes expressed in specific
organs, tissues, cell types or diseases. These are accom-
plished through the Basic Search (Figure 3A) and
Advanced Search windows (below), respectively. In the
Basic Search window the user has several options:
1) choose a particular TF family or multiple families and
display all genes containing binding sites for those
families (Figure 3A, arrow 1, Option 1), 2) chose a speci-
fic gene or genes and display all binding sites on those
genes (Figure 3A, arrow 2, Option 2), 3) choose a specific
TF listed and show all genes containing sites for that TF
(Figure 3A, arrow 3, Option 3). On the right side of the
basic search page one can search for TFs and genes in
the database based on commonly used synonyms if the
standard gene or TF names are not known (Figure 3A,
arrow 4, Synonym Search). For example inputting P53
opens a window showing all P53 genes in the database
(Figure 3B). Note that while p53 is indeed a TF, none of
the genes in the database contain known binding sites for
p53 and therefore it is listed here only as a gene. Clicking
on the gene link in the search menu will display binding
site information for the gene.
From this page one can also perform searches of
NCBI for gene names (Figure 3A, arrow 5, NCBI Gene
Search), perform a BLAT search for a specific sequence
at the UCSC Genome Bioinformatics site from selected
genome database builds (Figure 3A, arrow 6, BLAT), or
perform a free text search of Pubmed to find articles
related to specific genes or TFs (Figure 3A, arrow 7,
Pubmed Search).
The Simple Sequence Viewer is used to display a
selected sequence region of a single gene (Figure 3A,
arrow 8, Simple Sequence Viewer) with binding sites
shown in red (Figure 3C). Placing the cursor over a site
in the window will display information on the site
(Figure 3C, arrow 1, transcription_start). In addition
from the viewer one can change the regions displayed
(Figure 3C, bracket 2) and search for specific short
sequences within the displayed sequence (Figure 3C,
arrow 3, Sequence Finder). From this page the user can
also perform BLAT searches of sequences input by
either typing or cutting and pasting (Figure 3C, arrow 4,
BLAT).
Binding site displays
Binding sites for TFs can be displayed in a number of
ways. Selecting and submitting a TF family or gene
returns a display of the location of binding sites on the
single or multiple genes with a detailed listing of each
binding site shown below the summary (Figure 4). To
obtain a visual comparison of the genes either the pic-
ture OR graph view, or the table view can be used. The
picture view generates an image of each regulatory
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region displayed one below the other, aligned by one of
the transcription factors selected (Figure 5). The Graph
view gives a graphical distribution of all the binding
sites relative to one selected site (Figure 6). This allows
one to visualize the relative distributions of all of the
binding sites on the set of genes selected. The table
view returns a simple table of all sites and their loca-
tions relative to the ATG of the gene (Figure 7). Thus,
these different views allow one to either compare each
regulatory region with the others, or produce a com-
bined distribution of all binding sites on all the genes
within the set.
Advanced Search page
Here one can search for sets of genes by: 1) species
(Figure 8, arrow 1, Species), 2) those containing sites for
a specific TF family (Figure 8, arrow 2, Regulated by TF
(family), 3) those containing sites for a specific member
of a TF family (Figure 8, arrow 3, Regulated by TF (indi-
vidual)), 4) those either activated or repressed by NFI or
other TFs (Figure 8, arrow 4, NFI action and arrow 5,
Transcription Factor action, respectively), 5) the type of
Evidence for binding (Figure 8, arrow 6, Evidence type)
or 6) those genes expressed in specific cell types, tissues
or disease states (Figure 8, arrow 7, keywords). Currently
the keyword search is used to classify many characteris-
tics of the genes, but this is likely to change in future
versions of the database. This page contains a link to
the same Simple Sequence Viewer and also allows the
same searches of TF and Gene synonyms, NCBI, UCSC
and Pubmed as those on the Basic Search Page.
Interactions with other Bioinformatics sites
In addition to the NCBI, UCSC and Pubmed searchs
shown above, the user can generate an XML file suitable
for incorporation into OregAnno. This feature has been
used to distribute binding site information to Ore-
gAnno. Users can also generate gff files that allow the
sites for selected genes to be displayed on the UCSC
Genome browser at the UCSC Bioinformatics site.
Figure 3 Basic Search Page of NFI-Regulome Database. A) Basic Search Page showing options for searching. B) Result of search for P53 in
Synonym Search. C) Example of Simple Sequence view.
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Figure 4 Search Summary of a search for genes containing sites for the AP-4 family of TFs. The genes are presented at the top of the
page with the number of TFs and TF binding sites (TFBS) and a list of the sites and their locations. In detail, every site is listed along with its
location, sequence, whether the site activates or represses expression and whether the site has been experimentally verified. The display is
truncated at the bottom of the 1st binding site of PENK.
Figure 5 Picture view of genes aligned by NFI site. The regulatory regions are stacked horizontally with the binding sites listed above or
below each region. Colored wedges denote the relative orientation of each site when known.
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Proposed uses of the database
In its current form the database can be used to answer
such example queries as: 1) what are all the genes
expressed in liver that contain both NFI sites and CEBP
sites, or 2) what are all the genes that contain both GR,
AP-1 and NFI binding sites? Regulatory regions contain-
ing these specific sites can then be easily compared in
the picture view or table view to assess the relative dis-
tribution and spatial configuration/orientation of the
sites within the regulatory elements. When populated
with larger numbers of genes, the statistical significance
of the distributions seen could be obtained. In addition,
genes associated with specific disease states can be
obtained and their regulatory regions compared. As the
regulatory regions of more NFI-regulated genes are
examined, common features of regulatory regions that
contain NFI sites may well be discovered. In addition,
specific classes of TFs associated with the expression of
genes in specific tissues, cell types, stages in develop-
ment or disease states can be determined.
Future growth and management of the database
The current structure of the database is well-suited to the
task at hand. Moving forward, the schema of the database
will evolve in order to provide new features. These
include a method for allowing members of the commu-
nity to enter gene and regulatory region information, the
addition of a Disease-relatedness table, and the refactor-
ing of the database to improve the maintenance of rela-
tionships between regulatory regions and annotation
information.
Providing a method for members of the community to
curate data shown in the literature is important as it
allows multiple users from within the community to
enter information into the NFI-Regulome database with-
out requiring those users to be located in close proxi-
mity to the maintainers. The system will allow members
Figure 6 Graph View of genes containing AP-4 binding sites, aligned by ATG as 0. The height of the bar indicates the number of binding
sites of each type within the bin of 1000 bp. Bins can be adjusted in size.
Figure 7 Table view of genes returned by query for genes
containing AP-4 binding sites. The Gene Name, location of the
binding site, TF name and TF Family name are generated and
displayed by the database. This table can be used to create
modified displays of the sites or for the calculation of relative
locations and distributions of binding sites using other software.
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of the community to be provided with curator accounts,
thereby allowing them to enter annotation information
into the database. Entries provided by community cura-
tors will be placed in an “approval queue” where the
administrator will provide oversight of the curated infor-
mation and will have the ability to make any necessary
changes/edits to the curated information before it is
approved and incorporated into the dataset.
The underlying database will be refactored to utilize
the referential integrity constraints provided by the
underlying relational database. Referential integrity will
add enforceable constraints between related entries in
the database and will ensure that the state of the data
remains consistent [23]. This functionality is currently
provided by the software layer of the NFI-Regulome data-
base and by taking advantage of the features provided by
the underlying database we define these constraints at
the same time that the data and relationships are defined,
freeing the application developer from the need to
enforce the constraints and reducing the probability of
errors and/or inconsistent information in the data.
Comparison to other TF binding site databases
The goals and features of the NFI-Regulome database
appear unique among TF binding site databases. There
are a number of databases that are significantly larger
than the NFI-Regulome Database as assessed by the
number of binding sites annotated including TRANSFAC
[16], JASPAR [17], ORegAnno [3] and the ENCODE con-
tribution to the UCSC Genome Browser [4]. Species- and
Kingdom- specific TF binding site databases include Red-
Fly (Drosophila) [24,25], RegPrecise (prokaryotic) [26],
PlantPAN [27] and GRASSIUS [28], but none of these
contain mammalian TFs. The TIGER database [29] is
perhaps most similar to the NFI-Regulome database in
that tissue-specificity of gene expression is searchable
and lists of TF binding sites are shown. Also, TIGER gen-
erates lists of co-occurrence of TF binding sites that may
Figure 8 Advanced Search Page. This page allows the selection of genes based on multiple criteria including species, TF, whether a gene
appears activated or repressed by NFI or other TFs, the evidence for binding and keywords. The keyword search can identify the organ or cell
type of expression and disease-relatedness of a gene if these data are input by annotators.
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be biologically relevant. However the binding sites in
TIGER are predicted sites and their functions have not
been experimentally verified. In addition, none of these
databases can be conveniently queried for sets or combi-
nations of TFs on individual genes, display of their pre-
cise locations within the genes, or disease relatedness of a
given gene. Thus in these types of queries, and in the
ability to display multiple genes aligned by specific TF
binding sites, the NFI-Regulome Database provides a
unique resource. We are currently working to both
increase the number of genes annotated in the database
and to improve the annotation features and abilities of
the database.
The rate limiting step for input of data into the database
is the manual reading of papers by annotators and their
reformatting of the published sequence positions for sites
to the UCSC coordinates. Because these steps are labor-
intensive, we have restricted our current database to the
NFI transcription factors. However, we have produced a
“generic” database module that other laboratories can use
to annotate sites for transcription factors of interest and it
is available upon request. We hope eventually to produce
a distributed database “cloud” whereby other transcription
factor families can be queried for their cognate genes, site
location, tissue of expression and promoter/enhancer
architecture from a single website.
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